Know Cancer

or
forgot password
  • cancer clinical trials in la jolla, CA

  • Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors, Lymphoma, Neuroblastoma, Retinoblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Sarcoma
    flt3L in Treating Patients With Acute Myeloid Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Brain and Central Nervous System Tumors
    Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Unspecified Childhood Solid Tumor, Protocol Specific
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Sarcoma
    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Graft Versus Host Disease, Lymphoma
    Irinotecan in Treating Children With Refractory or Advanced Solid Tumors Who Are Receiving Anticonvulsants
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Unspecified Childhood Solid Tumor, Protocol Specific
    Interleukin-2 in Treating Children Who Have Undergone Bone Marrow Transplantation for Acute Myeloid Leukemia
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Karenitecin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Pancreatic Cancer
    Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
    Scripps Cancer Center at Scripps Clinic
    La Jolla, California 92037
    Liver Cancer
    Combination Chemotherapy in Treating Patients With Bladder Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Bladder Cancer
    NBI-3001 Followed by Surgery in Treating Patients With Recurrent Glioblastoma Multiforme
    UCSD Thornton Hospital
    La Jolla, California 92037
    Brain and Central Nervous System Tumors
    Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer
    Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
    Rebecca and John Moores UCSD Cancer Center

    Trial Locations
    Rebecca and John Moores UCSD Cancer Center
    Scripps Cancer Center
    Breast Cancer
    Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia, Lymphoma
    Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lymphoma
    Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer, Osteoporosis
    Tipifarnib in Treating Young Patients With Refractory Leukemia
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia
    Blood and Marrow Transplant Clinical Research Network
    University of California at San Diego
    La Jolla, California 92093
    Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Graft vs Host Disease
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer
    Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer
    Scripps Cancer Center at Scripps Clinic
    La Jolla, California 92037
    Drug/Agent Toxicity by Tissue/Organ, Pancreatic Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Pancreatic Cancer
    Irinotecan in Treating Aging Patients With Solid Tumors
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Unspecified Adult Solid Tumor, Protocol Specific
    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lymphoma
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer, Neoplasm Metastasis
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    University of California San Diego Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Kidney Cancer
    Decitabine Versus Supportive Care in Adults With Advanced-stage MDS
    Scripps Clinic
    La Jolla, California 92037
    Myelodysplastic Syndrome
    Study of T900607-Sodium in Previously Treated Patients With Non-Hodgkin's Lymphoma.
    Scripps Health Center
    La Jolla, California 92037
    Non-Hodgkin's Lymphoma
    Evaluation of Bay 59-8862 in Patients With Advanced Renal Cell Carcinoma
    Scripps Clinic - Torrey Pines
    La Jolla, California 92037
    Carcinoma, Renal Cell
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Breast Cancer
    National Lung Screening Trial (NLST) Screening
    Univeristy of California, San Diego
    La Jolla, California 92093-0658
    Lung Cancer
    Prialt (Ziconotide) In Severe Chronic Pain
    UCSD Medical Center, Thornton Hospital
    La Jolla, California 92037
    Pain
    Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus
    Scripps Health Center
    La Jolla, California 92037
    Gastric Cancer, Esophageal Neoplasms
    Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Colorectal Cancer, Diarrhea, Neutropenia
    A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
    University of California San Diego Moores Cancer Center
    La Jolla, California
    Pancreatic Cancer
    Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer
    UCSD Cancer Center
    La Jolla, California 92093-0064
    Esophageal Cancer
    Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Prostate Cancer
    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myeloproliferative Neoplasms
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Malignant Mesothelioma
    An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon Cancer
    University of California, San Diego
    La Jolla, California 92037-1709
    Colonic Neoplasms, Colorectal Neoplasms
    Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
    UCSD School of Medicine
    La Jolla, California 92093-0663
    Leukemia, Lymphocytic, Chronic
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Scripps Green Hospital
    La Jolla, California 92037
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    Rebecca and John Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Lung Cancer
    Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer
    Moores UCSD Cancer Center
    La Jolla, California 92093-0658
    Gestational Trophoblastic Tumor, Neurotoxicity, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients
    University of California, San Diego
    La Jolla, California 92037-1709
    Chronic Lymphocytic Leukemia
    Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
    University of California San Diego

    Trial Locations
    University of California San Diego
    Scripps Clinic - La Jolla
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Childhood Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Disseminated Neuroblastoma, Malignant Neoplasm, Ovarian Choriocarcinoma, Ovarian Embryonal Carcinoma, Ovarian Immature Teratoma, Ovarian Mature Teratoma, Ovarian Mixed Germ Cell Tumor, Ovarian Monodermal and Highly Specialized Teratoma, Ovarian Polyembryoma, Ovarian Yolk Sac Tumor, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Mantle Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage II Ovarian Epithelial Cancer, Stage III Malignant Testicular Germ Cell Tumor, Stage III Multiple Myeloma, Stage III Ovarian Epithelial Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Stage IV Ovarian Epithelial Cancer, Testicular Choriocarcinoma, Testicular Choriocarcinoma and Embryonal Carcinoma, Testicular Choriocarcinoma and Seminoma, Testicular Choriocarcinoma and Teratoma, Testicular Choriocarcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma, Testicular Embryonal Carcinoma and Seminoma, Testicular Embryonal Carcinoma and Teratoma, Testicular Embryonal Carcinoma and Teratoma With Seminoma, Testicular Embryonal Carcinoma and Yolk Sac Tumor, Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma, Testicular Teratoma, Testicular Yolk Sac Tumor, Testicular Yolk Sac Tumor and Teratoma, Testicular Yolk Sac Tumor and Teratoma With Seminoma